Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Jul 08, 2024 6:49pm
336 Views
Post# 36123565

Status recap…where are we now & future

Status recap…where are we now & future

Again, I'm limited in my time. Very serious family health issues.
Not looking for sympathy , just explaining my absence from our Stockhouse fun land.
Mr. noteable has done a great job of providing ample , clinical & technical details of Pelareorep's opportunities as a cotherapy treatement.
Not only for the recently updated from FDA tyle c meeting, but also breast cancer, and most recently favourable results from the Gobblet anal cancer cohort.
potentially others......
Yes, it has been a very long road.
Cancer as a disease, very complicated.
Treatments.?
, no two people react the same. 
The recent FDA advice & approvals for various requests. Good news.
The first enrolment of another Gobblet pancreatic cancer arm. Good news.
Progress?
They have a new VP if business development. Perhaps a better closer, than previous?
That realm, we know little about. Regarding Andrew's departure or his replacement.
Similar to Matt being off sick. Changes. 

To clarify.
Matt if you are reading this. I wish you the very best.
I know Pela is your life's work. 

ill reach out to I.R. With my contacts, if you are interested.
Am I emotionally attached to Onc?
Absolutely.
As I mentioned before.
from both my grandparents, to my own mother, cousins, aunts & uncles. All died of cancer.
All from same blood line. So yes a made in Canada cancer therapy would be wonderful.
The future?
We have been told O.S. For MBc coming next few months. Coukd that be the holdup for a phase 3 partner?
The FDA rulings are only 2 weeks old.
A Business development held up waiting for the FDA rulings, could now move ahead.
or longer wait to see the MBc O.S. Numbers.
either way, yet another quarter is over.
stay healthy all. 
 

<< Previous
Bullboard Posts
Next >>